Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo

Petit, V.; Guetard, D.; Renard, M.; Keriel, A.; Sitbon, M.; Wain-Hobson, S.; Vartanian, J. P.

Journal of molecular biology

2009-01-09 / vol 385 / pages 65-78


Mammalian APOBEC molecules comprise a large family of cytidine deaminases with specificity for RNA and single-stranded DNA (ssDNA). APOBEC1s are invariably highly specific and edit a single residue in a cellular mRNA, while the cellular targets for APOBEC3s are not clearly established, although they may curtail the transposition of some retrotransposons. Two of the seven member human APOBEC3 enzymes strongly restrict human immunodeficiency virus type 1 in vitro and in vivo. We show here that ssDNA hyperediting of an infectious exogenous gammaretrovirus, the Friend-murine leukemia virus, by murine APOBEC1 and APOBEC3 deaminases occurs in vitro. Murine APOBEC1 was able to hyperdeaminate cytidine residues in murine leukemia virus genomic RNA as well. Analysis of the edited sites shows that the deamination in vivo was due to mouse APOBEC1 rather than APOBEC3. Furthermore, murine APOBEC1 is able to hyperedit its primary substrate in vivo, the apolipoprotein B mRNA, and a variety of heterologous RNAs. In short, murine APOBEC1 is a hypermutator of both RNA and ssDNA in vivo, which could exert occasional side effects upon overexpression.

Read on PubMed

S0022-2836(08)01300-4 [pii] 10.1016/j.jmb.2008.10.043

1089-8638 (Electronic)

IGMM team(s) involved in this publication

Humans; Animals; Mice; NIH 3T3 Cells; Molecular Sequence Data; Base Sequence; Animals, Newborn; RNA, Messenger/genetics/metabolism; Genome, Viral/genetics; Mutation/*genetics; Apolipoproteins B/genetics; Cytidine Deaminase/*metabolism; DNA, Complementary/genetics; Hypoxanthine Phosphoribosyltransferase/genetics/metabolism; Leukemia Virus, Murine/genetics/*metabolism; Leukemia, Experimental/enzymology/genetics; Muscle Proteins/metabolism; Nucleic Acid Denaturation; Nucleotides; Retroviridae Infections/enzymology; RNA Editing/genetics; RNA/*genetics; Tumor Virus Infections/enzymology/genetics

Back to all publications